Tilray Brands, Inc. (TLRY) Insider Trading

Cluster buy

3 insiders bought $69k of their own stock in 4 days.

Open-market purchases by executives and directors between Aug 3 and Aug 6. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market

−$164k

3 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

3 / 1

executives and directors

Last open-market buy

Aug 2026

Aug 6, 2026

Get an email when TLRY's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 6	Mitchell Gendel Global General Counsel	Bought	2,500	$4.43	$11k	2.0%	Form 4
Aug 4	Carl A Merton Chief Financial Officer	Bought	10,000	$4.62	$46k	7.7%	Form 4
Aug 3	Denise M Faltischek Chief Strategy Officer	Bought	2,500	$4.78	$12k	1.8%	Form 4
Apr 21	David G. Hopkinson Director	SoldNo plan	33,556	$6.94	$233k	100%	Form 4
Jul 31, 2025	Mitchell Gendel Global General Counsel	Bought	6,000	$0.58	$3k	0.9%	Form 4
Jul 30, 2025	Irwin D Simon President and CEO	Bought	165,000	$0.61	$101k	4.4%	Form 4
Jul 30, 2025	Carl A Merton Chief Financial Officer	Bought	33,500	$0.60	$20k	4.4%	Form 4
Nov 15, 2024	Carl A Merton Chief Financial Officer	Bought	26,000	$1.36	$35k	3.9%	Form 4

Aug 6
Mitchell Gendel
Global General Counsel · bought 2,500 at $4.43
$11k
2.0% of stake
Aug 4
Carl A Merton
Chief Financial Officer · bought 10,000 at $4.62
$46k
7.7% of stake
Aug 3
Denise M Faltischek
Chief Strategy Officer · bought 2,500 at $4.78
$12k
1.8% of stake
Apr 21No plan
David G. Hopkinson
Director · sold 33,556 at $6.94
$233k
100% of stake
Jul 31, 2025
Mitchell Gendel
Global General Counsel · bought 6,000 at $0.58
$3k
0.9% of stake
Jul 30, 2025
Irwin D Simon
President and CEO · bought 165,000 at $0.61
$101k
4.4% of stake
Jul 30, 2025
Carl A Merton
Chief Financial Officer · bought 33,500 at $0.60
$20k
4.4% of stake
Nov 15, 2024
Carl A Merton
Chief Financial Officer · bought 26,000 at $1.36
$35k
3.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TLRY, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Medicinal Chemicals & Botanical Products

USNAUsana Health Sciences, Inc.

TCNNFTrulieve Cannabis Corp.

AAWHAscend Wellness Holdings, Inc.

CGCCanopy Growth Corporation

JUSHFJushi Holdings Inc.

BTMDBiote Corp.

CRONCronos Group Inc.

MRMDMariMed Inc.

Spot a number that looks wrong? Check it in TLRY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TLRY

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.